Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
批准号:
10216348
负责人:
NASIA SAFDAR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-10-01 至 2022-03-31
关键词:
AffectAmericanAmericasAntimicrobial ResistanceBehaviorCaringCessation of lifeClostridium difficileCommunicable DiseasesComplementComplexContainmentDataData CollectionDecontaminationDiagnosticDiagnostic testsDiarrheaDisinfectionEducational InterventionElementsEngineeringEnsureEnvironmental PollutionEvaluationFactor AnalysisFinancial HardshipFundingGenerationsGuidelinesHandHealth PersonnelHealth ServicesHealth care facilityHealthcareHospitalsHygieneIncidenceIndividualInfectionInfection ControlInfection preventionInstitutionInterventionInterviewLeadershipLiteratureMeasuresMedicalMentorsMethodologyMethodsModelingMonitorMotivationNursesParticipantPatient IsolationPatientsPatients&apos RoomsPhysiciansPilot ProjectsPreventionPrevention strategyPreventive measureProcessProviderPublishingResearchResourcesRiskService delivery modelServicesSeveritiesSiteSocietiesSpecific qualifier valueStructureSystemSystems AnalysisTimeTrainingTraining and EducationVariantVeteransWorkbasecomparativecontextual factorscostdiarrheal diseasedirect patient careevidence baseexperiencehealthcare-associated infectionsimplementation facilitatorsimplementation strategyimprovedinfection rateinnovationmethicillin resistant Staphylococcus aureusmotivational interventionmulti-drug resistant pathogenpathogenpatient safetyportabilitypreventprogramspublic health prioritiesrapid diagnosisresearch studyskill acquisitionskillsstemsuccesstheoriestooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: C. difficile infection (CDI) is increasing in incidence and severity; CDI affects 500,000 Americans
each year, causes 20,000 deaths annually, and imposes a significant financial burden on healthcare
institutions. Preventing CDI is essential, and the VA Multidrug Resistant Organism (MDRO) Program Office
recently mandated a bundle for prevention of CDI in VA facilities. The bundle includes appropriate diagnostic
testing, optimization of hand hygiene compliance, contact isolation for CDI, and environmental cleaning of
rooms of patients with CDI. However, it does not address optimum implementation strategies to ensure
successful application of these interventions, nor does it prescribe how these measures may be undertaken.
Implementing and adhering to these recommended measures varies considerably across institutions.
Specific Aims: The central hypothesis of this project is that variation in practices and approaches related to
environmental cleaning—particularly daily cleaning—will emerge as major contributors to variable
implementation of the CDI bundle and CDI rates. The rationale stems from the literature identifying frequent
environmental contamination with C. difficile and the findings of our pilot work. Our objective is to assess work
system barriers and facilitators to bundle implementation using a mixed-methods approach. The specific aims
for this project are:
1. To evaluate the association between existing CDI bundle implementation and CDI rates at 10 VA sites.
2. To identify practices that facilitate or impede CDI bundle implementation at 10 VA sites.
3. Pilot and finalize tools to improve environmental cleaning at one VA site using the rapid plan-do-study-
act cycle methodology of quality improvement.
Methods: We will use the innovative Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 model of
work system and patient safety as the study framework integrated with the iPARiHS framework. This model, as
well as general literature on guideline implementation, will guide interview questions. Participants will include
nurses, physicians, patients, environmental services and hospital leadership. We will conduct direct
observations of healthcare workers based on the SEIPS 2.0 model. We will observe patient rooms, individuals,
tasks, and organization to better understand the overall work system that surrounds the process of care for
CDI patients.
Impact: Prevention of Clostridium difficile is a priority of the VA, and implementation of a C. difficile prevention
bundle, akin to an already established methicillin-resistant Staphylococcus aureus (MRSA) bundle, has
recently been rolled out nationally. However, our ability to devise and implement strategies for containment of
C. difficile is hampered by a limited understanding of factors influencing acquisition, spread, and prevention of
C. difficile in VA facilities. Immediate benefits of achieving the objectives of this proposal will be generation of
important data regarding barriers and facilitators of implementation using a systems engineering approach.
Our study will produce data, methods, and tools that have widespread relevance and portability, with the
potential to reduce healthcare-associated infections (HAIs) including but not limited to C. difficile infection.
This is the first research study to systematically examine barriers and facilitators of implementation of a
prevention bundle for CDI. Our project is innovative in that it will employ the SEIPS 2.0 framework to undertake
a complete work systems analysis for CDI prevention; use a number of complementary approaches to data
collection; and consider not just healthcare workers involved in direct patient care, but also ancillary staff who
are critical to successful CDI prevention. Our study methods and approach may be widely used not just for CDI
but also other HAIs, and will add to the fields of patient safety and infection control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCCMA: Targeting Gut-Microbiome in Veterans Deployment related Gastrointestinal and Liver diseases; CMA5- Functional metagenomics in GWI-related gut dysfunction
-
批准号:10588620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:10641758
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:10404905
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:9720132
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Reducing VA Healthcare-Associated Infections through Antibiotic StEwardship (RAISE)
-
批准号:10181069
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Identification of novel MDR antimicrobials from human microbiome symbioses
-
批准号:10592388
-
项目类别:
-
资助金额:$126.61万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Identification of novel MDR antimicrobials from human microbiome symbioses
-
批准号:10571221
-
项目类别:
-
资助金额:$106.02万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients
-
批准号:10462715
-
项目类别:
-
资助金额:$102.21万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:9753142
-
项目类别:
-
资助金额:$49.04万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:10165788
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:10411933
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
-
批准号:10290896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients
-
批准号:10241381
-
项目类别:
-
资助金额:$100.54万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
-
批准号:10202724
-
项目类别:
-
资助金额:$46.47万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
-
批准号:9424172
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
The GRAFT study: Gut RecolonizAtion by Fecal Transplantation
-
批准号:9297849
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
Building implementation science for VA healthcare associated infection prevention
-
批准号:9063308
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare study
-
批准号:9301469
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare study
-
批准号:8932185
-
项目类别:
-
资助金额:$48.89万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
Barriers and Facilitators for Clostridium difficile Bundle Implementation
-
批准号:8671210
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:NASIA SAFDAR
-
依托单位:
海外基金